Technical Description
This invention relates to stable nanoarchaeosome compositions encapsulating tumor proteins for targeted cervical cancer immunotherapy. It details a specific lipid-protein formulation and a freeze-thaw sonication method to prepare high-stability Nano carriers that enhance cell-mediated immune responses.
Problems Addressed
- Type-Restricted Vaccine Efficacy
- High-Cost Production Burdens
- Low In-Vivo Immunogenicity
- Inefficient Naked Administration
- Fast Enzymatic Degradation
- Unstable Conventional Liposome
Tech Features
- Enhanced Formulation Stability
- Efficient Antigen Encapsulation
- Targeted Lympho Delivery
- Enhanced Marker Expression
- Enhanced IFN-gamma Production
- Scalable Processing Method
Target Audience
- Pharmaceutical Manufacturing Sectors
- Biotechnology Research Industries
- Cancer Immunotherapy Sectors
- Nanomedicine Production Industries
- Clinical Vaccine Development Sectors
- Research & Development
Tech ID: P26-2025 TRL 5 Patent Status: Granted Available For Exclusive and Non-exclusive License
